Nicotinell Lakrids (Nicotine Polacrilex)

Nicotine Polacrilex, the active ingredient in Nicotinell Lakrids, is a nicotine replacement therapy presented as a buccal lozenge for buccal use. It helps adult smokers manage nicotine withdrawal symptoms when attempting to quit tobacco. The product is formulated for convenient, discreet administration and is marketed throughout the European Union.

GNH USA supplies Nicotinell Lakrids as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant shipping to health‑care institutions across multiple continents.

Nicotinell Lakrids is a nicotine replacement therapy used within the smoking cessation pathway.

- Smoking cessation: helps adult smokers reduce withdrawal symptoms while quitting. - Tobacco dependence: provides controlled nicotine to aid gradual reduction of use. - Relapse prevention: supports individuals who have recently quit to maintain abstinence.

Adverse reactions may occur with buccal nicotine delivery.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat irritation: transient discomfort or scratchiness. - Nausea: occasional feeling of queasiness. - Hiccups: brief, involuntary diaphragm spasms. - Increased salivation: excess saliva production. - Dyspepsia: mild indigestion.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling. - Chest pain: unexplained discomfort in the chest area. - Irregular heartbeat: palpitations or arrhythmia. - Severe mouth ulcer: persistent ulceration. - Anaphylaxis: severe, life‑threatening allergic response. - Severe dizziness: marked vertigo or loss of balance.

Before using Nicotinell Lakrids, consider the following safety measures.

- Medical assessment: confirm the patient is an adult smoker seeking cessation. - Contraindications: avoid in individuals with known hypersensitivity to nicotine. - Pregnancy: use only if benefits outweigh risks; consult a healthcare professional. - Cardiovascular disease: monitor closely if the patient has recent myocardial infarction or uncontrolled hypertension. - Concurrent nicotine products: do not use together with other nicotine replacement therapies. - Store at room temperature: keep in the original pack, protect from moisture and heat.

Nicotinell Lakrids may interact with other medicines.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase hypertensive risk. - Beta‑blockers: nicotine may mask tachycardia symptoms. - CYP2A6 inhibitors: can raise nicotine plasma levels.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance nicotine's cardiovascular effects. - Caffeine: may increase jitteriness or nervousness.